RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer
2008 Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion
2011 C. Carmi; A. Lodola; S. Rivara; F. Vacondio; A. Cavazzoni; R.R. Alfieri; A. Ardizzoni; P.G. Petronini; M. Mor
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: current status and future perspective in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer.
2012 Galvani E; Alfieri R; Giovannetti E; Cavazzoni A; Monica SL; Galetti M; Fumarola C; Bonelli M; Mor M; Tiseo M; Peters GJ; Petronini PG; Ardizzoni A
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer - The role of anthrocycline dose intensity
2006 Bozzetti C; Musolino A; Camisa R; Bisagni G; Flora M; Bassano C; Martella E; Lagrasta C; Nizzoli R; Personeni N; Leonardi F; Cocconi G; Ardizzoni A
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
2009 La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Ardizzoni A; Tiseo M; Capelletti M; Goldoni M; Tagliaferri S; Mutti A; Fumarola C; Bonelli M; Generali D; Petronini PG
First LineTreatment in advanced non small-cell lung cancer: the emerging role of the histologic subtype
2009 M. Tiseo; M. Bartolotti; F. Gelsomino; Ardizzoni A
Functional characterization of gefitinib uptake in non small cell lung cancer cell lines
2010 GALETTI M; ALFIERI R.R; CAVAZZONI A; LA MONICA S; BONELLI M; FUMAROLA C; MOZZONI P; DE PALMA G; ANDREOLI R; MUTTI A; MOR M; TISEO M; ARDIZZONI A; PETRONINI P.G
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development Group
2004 Giaccone G; Smit EF; de Jonge M; Dansin E; Briasoulis E; Ardizzoni A; Douillard JY; Spaeth D; Lacombe D; Baron B; Bachmann P; Fumoleau P
HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis
2011 Negri FV; Bozzetti C; Ardizzoni A; Lagrasta C; Crafa P; Silini EM
HER2 STATUS AS PREDICTOR OF MAMMOGRAPHIC SCREENING DETECTION: COMPARISON OF INTERVAL- AND SCREEN-DETECTED BREAST CANCERS
2010 Musolino A; Michiara M; Conti GM; Boggiani D; Bozzani F; Zatelli M; Sgargi P; Ardizzoni A
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer | Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Ga...letti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A | 2008-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion | C. Carmi; A. Lodola; S. Rivara; F. Vacondio; A. Cavazzoni; R.R. Alfieri; A. Ardizzoni; P.G. Petro...nini; M. Mor | 2011-01-01 | MINI-REVIEWS IN MEDICINAL CHEMISTRY | - | 1.04 Replica / breve intervento (e simili) | - |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: current status and future perspective in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer. | Galvani E; Alfieri R; Giovannetti E; Cavazzoni A; Monica SL; Galetti M; Fumarola C; Bonelli M; Mo...r M; Tiseo M; Peters GJ; Petronini PG; Ardizzoni A | 2012-01-01 | CURRENT PHARMACEUTICAL DESIGN | - | 1.04 Replica / breve intervento (e simili) | - |
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer - The role of anthrocycline dose intensity | Bozzetti C; Musolino A; Camisa R; Bisagni G; Flora M; Bassano C; Martella E; Lagrasta C; Nizzoli ...R; Personeni N; Leonardi F; Cocconi G; Ardizzoni A | 2006-01-01 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS | - | 1.04 Replica / breve intervento (e simili) | - |
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines | La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Ardizzoni A; Tiseo M; Capelletti M; Goldoni M; T...agliaferri S; Mutti A; Fumarola C; Bonelli M; Generali D; Petronini PG | 2009-01-01 | BIOCHEMICAL PHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
First LineTreatment in advanced non small-cell lung cancer: the emerging role of the histologic subtype | M. Tiseo; M. Bartolotti; F. Gelsomino; Ardizzoni A | 2009-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.04 Replica / breve intervento (e simili) | - |
Functional characterization of gefitinib uptake in non small cell lung cancer cell lines | GALETTI M; ALFIERI R.R; CAVAZZONI A; LA MONICA S; BONELLI M; FUMAROLA C; MOZZONI P; DE PALMA G; A...NDREOLI R; MUTTI A; MOR M; TISEO M; ARDIZZONI A; PETRONINI P.G | 2010-01-01 | BIOCHEMICAL PHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer: a phase II trial of the EORTC-New Drug Development Group | Giaccone G; Smit EF; de Jonge M; Dansin E; Briasoulis E; Ardizzoni A; Douillard JY; Spaeth D; Lac...ombe D; Baron B; Bachmann P; Fumoleau P | 2004-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis | Negri FV; Bozzetti C; Ardizzoni A; Lagrasta C; Crafa P; Silini EM | 2011-01-01 | HUMAN PATHOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
HER2 STATUS AS PREDICTOR OF MAMMOGRAPHIC SCREENING DETECTION: COMPARISON OF INTERVAL- AND SCREEN-DETECTED BREAST CANCERS | Musolino A; Michiara M; Conti GM; Boggiani D; Bozzani F; Zatelli M; Sgargi P; Ardizzoni A | 2010-01-01 | ANNALS OF ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 - Contributo in rivista 69
- 1 - Contributo in rivista::1.04 R... 69
Data di pubblicazione
- 2020 - 2023 2
- 2010 - 2019 17
- 2004 - 2009 50
Rivista
- LUNG CANCER 10
- JOURNAL OF CLINICAL ONCOLOGY 8
- JOURNAL OF THORACIC ONCOLOGY 8
- ANNALS OF ONCOLOGY 5
- BRITISH JOURNAL OF CANCER 5
- CANCER 4
- TUMORI 3
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- BIOCHEMICAL PHARMACOLOGY 2
- EUROPEAN JOURNAL OF CANCER 2
Keyword
- NSCLC 10
- EGFR 8
- non-small cell lung cancer 8
- gefitinib 7
- cisplatin 5
- breast cancer 4
- chemotherapy 4
- erlotinib 3
- FISH 3
- non small cell lung cancer 3
Lingua
- eng 69
Accesso al fulltext
- no fulltext 69